JCI - Citations to What brings pericytes to tumor vessels?

Citations to this article

What brings pericytes to tumor vessels?

Rakesh K. Jain, Michael F. Booth

Rakesh K. Jain, Michael F. Booth

Published October 15, 2003
Citation Information: J Clin Invest. 2003;112(8):1134-1136. https://doi.org/10.1172/JCI20087.

View: Text | PDF

Total citations by year

Year:	2025	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2005	2004	Total
Citations:	1	1	2	2	1	1	6	3	4	6	3	5	10	6	4	3	2	3	1	64

Citation information

Citations to this article (65)

Title and authors	Publication	Year
Integrated single-cell RNA sequencing reveals the tumor heterogeneity and microenvironment landscape during liver metastasis in adenocarcinoma of esophagogastric junction Xu J, Sadiq U, Zhao W, Xia H, Liu Y, Zhang R, Xu A	Frontiers in Immunology	2025
Microvascular Changes in Parkinson’s Disease- Focus on the Neurovascular Unit G Paul, O Elabi	Frontiers in aging neuroscience	2022
Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities M Groblewska, B Mroczko	International journal of molecular sciences	2021
Neural crest cell-derived pericytes act as pro-angiogenic cells in human neocortex development and gliomas F Girolamo, I de Trizio, M Errede, G Longo, A dAmati, D Virgintino	Fluids and barriers of the CNS	2021
Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment Y Zhao, X Yu, J Li	Acta pharmaceutica Sinica. B	2020
Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models C Ceci, MG Atzori, PM Lacal, G Graziani	International journal of molecular sciences	2020
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation. Wang JC, Li GY, Wang B, Han SX, Sun X, Jiang YN, Shen YW, Zhou C, Feng J, Lu SY, Liu JL, Wang MD, Liu PJ	Journal of experimental & clinical cancer research : CR	2019
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis A Prete, AS Lo, PM Sadow, SS Bhasin, ZA Antonello, DM Vodopivec, S Ullas, JN Sims, J Clohessy, AM Dvorak, T Sciuto, M Bhasin, JE Murphy-Ullrich, J Lawler, SA Karumanchi, C Nucera	Clinical cancer research	2018
The inner blood-retinal barrier: Cellular basis and development M Díaz-Coránguez, C Ramos, DA Antonetti	Vision research	2017
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation E Allen, A Jabouille, LB Rivera, I Lodewijckx, R Missiaen, V Steri, K Feyen, J Tawney, D Hanahan, IP Michael, G Bergers	Science Translational Medicine	2017
Transport of drugs from blood vessels to tumour tissue MW Dewhirst, TW Secomb	Nature Reviews Cancer	2017
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? RR Ramjiawan, AW Griffioen, DG Duda	Angiogenesis	2017
Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics. Mamer SB, Chen S, Weddell JC, Palasz A, Wittenkeller A, Kumar M, Imoukhuede PI	Scientific Reports	2017
Suppression of hypoxia-induced excessive angiogenesis by metformin via elevating tumor blood perfusion Wang JC, Li GY, Li PP, Sun X, Li WM, Li Y, Lu SY, Liu PJ	Oncotarget	2017
The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment SA Hendry, RH Farnsworth, B Solomon, MG Achen, SA Stacker, SB Fox	Frontiers in immunology	2016
Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma Incorvaia L, Bronte G, Bazan V, Badalamenti G, Rizzo S, Pantuso G, Natoli C, Russo A	Oncotarget	2016
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours Berardi R, Morgese F, Torniai M, Savini A, Partelli S, Rinaldi S, Caramanti M, Ferrini C, Falconi M, Cascinu S	World journal of gastrointestinal oncology	2016
Adaptation to antiangiogenic therapy in neurological tumors PM Flanigan, MK Aghi	Cellular and Molecular Life Sciences	2015
Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy V Gkretsi, A Stylianou, P Papageorgis, C Polydorou, T Stylianopoulos	Frontiers in Oncology	2015
PDGF upregulates CLEC-2 to induce T regulatory cells Agrawal S, Ganguly S, Hajian P, Cao JN, Agrawal A	Oncotarget	2015
Pathogenesis of Systemic Sclerosis D Pattanaik, M Brown, BC Postlethwaite, AE Postlethwaite	Frontiers in immunology	2015
Role of BRAFV600E in the First Preclinical Model of Multifocal Infiltrating Myopericytoma Development and Microenvironment PM Sadow, C Priolo, S Nanni, FA Karreth, M Duquette, R Martinelli, A Husain, J Clohessy, H Kutzner, T Mentzel, CV Carman, A Farsetti, EP Henske, E Palescandolo, LE Macconaill, S Chung, G Fadda, CP Lombardi, AM de Angelis, O Durante, JA Parker, A Pontecorvi, HF Dvorak, C Fletcher, PP Pandolfi, J Lawler, C Nucera	JNCI Journal of the National Cancer Institute	2014
Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth G Sarkisyan, LJ Gay, N Nguyen, BH Felding, H Rosen	American journal of physiology. Cell physiology	2014
Resistance to Antiangiogenic Therapy SP Weathers, J de Groot	Current Neurology and Neuroscience Reports	2014
Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma J Kalpathy-Cramer, ER Gerstner, KE Emblem, OC Andronesi, B Rosen	Cancer research	2014
Targeting angiogenesis in advanced cervical cancer RN Eskander, KS Tewari	Therapeutic advances in medical oncology	2014
Hydrogels to Model 3D in vitro Microenvironment of Tumor Vascularization Song HH, Park KM, Gerecht S	Advanced Drug Delivery Reviews	2014
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization F Amparo, Z Sadrai, Y Jin, B Alfonso-Bartolozzi, H Wang, H Shikari, JB Ciolino, J Chodosh, U Jurkunas, DA Schaumberg, R Dana	Investigative ophthalmology & visual science	2013
A review of tasquinimod in the treatment of advanced prostate cancer SC Williamson, AE Hartley, R Heer	Drug design, development and therapy	2013
Leptin's Pro-Angiogenic Signature in Breast Cancer RR Gonzalez-Perez, V Lanier, G Newman	Cancers	2013
Role of Bone Marrow-Derived Cells in Angiogenesis: Focus on Macrophages and Pericytes Y Ding, N Song, Y Luo	Cancer Microenvironment	2012
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease S Goel, AH Wong, RK Jain	Cold Spring Harbor Perspectives in Medicine	2012
Beyond antiangiogenesis: vascular modulation as an anticancer therapy-a review. Oronsky BT, Scicinski JJ, Reid T, Knox S	Translational oncology	2012
Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer. Kono SA, Heasley LE, Doebele RC, Camidge DR	Current cancer drug targets	2012
p19Arf Represses Platelet-Derived Growth Factor Receptor β by Transcriptional and Posttranscriptional Mechanisms Widau RC, Zheng Y, Sung CY, Zelivianskaia A, Roach LE, Bachmeyer KM, Abramova T, Desgardin A, Rosner A, Cunningham JM, Skapek SX	Molecular and cellular biology	2012
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES S Goel, DG Duda, L Xu, LL Munn, Y Boucher, D Fukumura, RK Jain	Physiological reviews	2011
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization Z Chaoran, L Zhirong, X Gezhi	Graefe's Archive for Clinical and Experimental Ophthalmology	2011
Developmental antiangiogenic agents for the treatment of Non-Small Cell Lung Cancer (NSCLC) GR Blumenschein	Investigational New Drugs	2011
Targeting angiogenesis from multiple pathways simultaneously: BIBF 1120, an investigational novel triple angiokinase inhibitor ES Santos, JE Gomez, LE Raez	Investigational New Drugs	2011
Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer R Salgia	Cancer	2011
PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer J Liu, S Liao, Y Huang, R Samuel, T Shi, K Naxerova, P Huang, W Kamoun, RK Jain, D Fukumura, L Xu	Clinical cancer research	2011
Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas P Tonino, C Abreu	Cancers	2011
Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma H Kim, C Catana, EM Ratai, OC Andronesi, DL Jennings, TT Batchelor, RK Jain, AG Sorensen	Cancer research	2011
Inorganic-Organic Hybrid Nanomaterials for Therapeutic and Diagnostic Imaging Applications Vivero-Escoto JL, Huang YT	International journal of molecular sciences	2011
Hypoxia and Prostaglandin E Receptor 4 Signalling Pathways Synergise to Promote Endometrial Adenocarcinoma Cell Proliferation and Tumour Growth Catalano RD, Wilson MR, Boddy SC, McKinlay AT, Sales KJ, Jabbour HN	PloS one	2011
Neuropilin-1 Enhances PDGF and TGFβ Dependent Hepatic Stellate Cell Signaling Thereby Promoting Liver Cirrhosis Sheng Cao, Usman Yaqoob, Amitava Das, Uday Shergill, Kumaravelu Jagavelu, Robert Huebert, Chittaranjan Routray, Soha Abdelmoneim, Meher Vasdev, Edward B. Leof, Michael R. Charlton, Ryan Watts, Debabrata Mukhopadhyay, Vijay Shah	Journal of Clinical Investigation	2010
Tumor Angiogenesis: Insights and Innovations F Nussenbaum, IM Herman	Journal of Oncology	2010
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure C Lu-Emerson, AD Norden, J Drappatz, EC Quant, R Beroukhim, AS Ciampa, LM Doherty, DC LaFrankie, S Ruland, PY Wen	Journal of Neuro-Oncology	2010
Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1 K Dhar, G Dhar, M Majumder, I Haque, S Mehta, PJ Veldhuizen, SK Banerjee, S Banerjee	Molecular Cancer	2010
“Mesenchymal” Stem Cells in Human Bone Marrow (Skeletal Stem Cells): A Critical Discussion of Their Nature, Identity, and Significance in Incurable Skeletal Disease P Bianco, PG Robey, I Saggio, M Riminucci	Human Gene Therapy	2010
Topical delivery of mesenchymal stem cells and their function in wounds JM Sorrell, AI Caplan	Stem Cell Research & Therapy	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
Paradoxical effects of PDGF-BB overexpression in endothelial cells on engineered blood vessels in vivo P Au, J Tam, DG Duda, PC Lin, LL Munn, D Fukumura, RK Jain	The American Journal of Pathology	2009
Modes of resistance to anti-angiogenic therapy G Bergers, D Hanahan	Nature Reviews Cancer	2008
Migratory neighbors and distant invaders: tumor-associated niche cells J Wels, RN Kaplan, S Rafii, D Lyden	Genes & development	2008
Integrin alpha4beta1-VCAM mediated adhesion between endothelial and mural cells is required for blood vessel maturation Barbara Garmy-Susini, Hui Jin, Yuhong Zhu, Rou-Jia Sung, Rosa Hwang and Judy Varner	Journal of Clinical Investigation	2005
A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas KJ Sales, T List, SC Boddy, AR Williams, RA Anderson, Z Naor, HN Jabbour	Cancer research	2005
Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye RL Silva, JD Thornton, AC Martin, JE Rehg, D Bertwistle, F Zindy, SX Skapek	The EMBO Journal	2005
Blasts from the past PA Insel, S Kornfeld, PW Majerus, AR Marks, PA Marks, AS Relman, BF Scharschmidt, TP Stossel, AP Varki, SJ Weiss, JD Wilson	Journal of Clinical Investigation	2004
Sequence of treatment in locally advanced and metastatic renal cell carcinoma Stefanie Fischer, Silke Gillessen, Christian Rothermundt	Translational andrology and urology
Influence of adult mesenchymal stem cells on in vitro vascular formation JM Sorrell, MA Baber, AI Caplan	Tissue Engineering Part A	2009
Structural Adaptation and Heterogeneity of Normal and Tumor Microvascular Networks Pries AR, Cornelissen AJ, Sloot AA, Hinkeldey M, Dreher MR, Höpfner M, Dewhirst MW, Secomb TW	PLoS computational biology	2009
Angiogenesis in the human corpus luteum: Angiogenesis in human CL N Sugino, A Matsuoka, K Taniguchi, H Tamura	Reproductive Medicine and Biology	2008
Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma-a rationale for a molecular targeting strategy? Drescher D, Moehler M, Gockel I, Frerichs K, Müller A, Dünschede F, Borschitz T, Biesterfeld S, Holtmann M, Wehler T, Teufel A, Herzer K, Fischer T, Berger MR, Junginger T, Galle PR, Schimanski CC	World journal of gastroenterology : WJG	2007
Loss of smooth muscle calponin results in impaired blood vessel maturation in the tumor–host microenvironment Yamamura H, Hirano N, Koyama H, Nishizawa Y, Takahashi K	Cancer Science	2007

Advertisement